Yes, the pump to $23 was the industry consolation prize for the insiders to cash out before the product was sidelined cause it's not a real high tech drug, and the retail screw job officially commenced.
1) Throw out Per Wold-Olsen as Chair of BoD (he's a dinosaur) 2) Vote for Patrice Bonfiglio (She will be Denner's coveted mouthpiece) 3) Vote for Dr. Paul Cohen (he's qualified; at least semi-independent) 4) Vote against Mark DiPaolo (he has shown his worthlessness on Innoviva board.) 5) Abstain on Keith Horn (don't need more yes-men) 6) Vote against Odysseas Kostas (worthless on Innoviva board) 7) Vote for Louis Sterling (smart; will ensure communities of color are a CV focus) 8) Vote for Diane Sullivan (fine background)
Essentially following LTRO's recommendation.
Before I pull the trigger, just wondering what's the downside compared with a straight "YES" vote across the board. TIA.